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INTRODUCTION 
Cancers are the cause of 8% of all deaths and the ninth 
major cause of mortality in average-income countries of 
the world.1 According to World Health Organization 
(WHO) reports, cancer-induced mortality rate will have 
increased about 80-100% in the middle-east by the next 
15 years.2 
Skin cancer is the most common human cancer in the 
world. 3 This cancer occurs as the most frequent cancer in 
males and as the second highest rank cancer in females, 
of which frequency is steadily increasing.4 It is also the 
most common cancer in the middle-east.5 
Skin cancer is an important skin disease. The skin tumors 
may originate from Basal Cell Carcinoma (BCC), 
Squamous Cell Carcinoma (SCC), melanocytic cells 
(malignant melanoma), immune cells such as lymphoma, 
skin appendages, vascular tissue, and connective or 
metastatic tissue.6 
According to WHO records, annually there are 2-3 
million cases of this type of cancer in the world, and this 
cancer forms one third of all cancers.7 Malignant skin 
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cancer is the most common in most countries of the 
world, and according to predictions, this disease will be 
an important factor in total disease load in the next 
decade.8 However, more painful than the pain of death 
due to cancer is the emotional and physical suffering 
resulting from it In addition, researchers have failed to 
take great steps in understanding etiology and molecular 
basis of cancer.4 
Skin malignancy is one of prevalent malignancies. BCC 
and SCC are the most common malignant non-melanoma 
skin tumors. BCC is the most prevalent tumor in white 
race, that is more than 99% of patients are white-
skinned.9 As one ages, especially after 40, BCC incidence 
rate increases.  Some risk factors are sun exposure and 
fair skin. In 85% of cases, BCC develops on head and 
neck 25-35% of which develops on nose. Although back 
of the hands are more exposed to sun, BCC incidence is 
very rare in them. BCC is usually in the form of local 
invasion, but sometimes metastasis occurs too. After 
BCC, SCC is the most common non-melanoma tumor in 
which, unlike BCC, metastasis is very likely. SCC is 
most common among middle-ages and old populations 
and is twice more prevalent in males than in females. 
Factors such as UVB, X radiation, immunodeficiency, 
and sunlight are among risk factors. Like BCC, SCC is 
more common in the skin areas that are highly exposed to 
sun. Both BCC and SCC are diagnosed through biopsy. 
Melanoma, a dangerous malignant tumor which can 
produce metastasis to all organs, mostly occurs in 
females of 25-29 ages. The rate of melanoma incidence is 
increasing and is more prevalent in white race. Probably 
sun causes melanoma through cutaneous 
immunosuppression. Hence, by avoiding massive 
exposure to sun, one can protect himself against 
melanoma.9  
After Bcc, SCC is the most common non-melanoma 
cancer in white race, which unlike BCC, is highly prone 
to metastasis. It can be widely seen among the middle-
aged and old, and is approximately twice more prevalent 
in males than in females. It is also the most prevalent 
cancer in southern latitudes such as Australia.10 Solar 
factors such as UVB induce DNA destruction and 
immunosuppression. Arsenic hydrocarbons, thermal 
factors such as infrared, X ray, thermal burn scars, 
verrucaos carcinoma, HPV, and immunodeficiency can 
be referred as its risk factors.9 Both SCC and BCC mostly 
develop in the areas that receive prolonged exposure to 
sun. SCC develops on head, back of the hand, and upper 
part of auricle, whereas BCC rarely develops in these 
parts.1 Although numerous factors have been suggested to 
play role in its incidence, the major factor for SCC is not 
known yet. A study in Australia showed that reduced sun 
exposure decreased incidence of SCC and keratoz actinic 
in children. Melanoma is a dangerous and malignant 
tumor which originates from melanocytic system cells, 
and can produce metastasis to any organ. It is the most 
common cancer in 25-29 age range and the second major 
cause of cancer in females of 30-34 ages.10 
Annually, 51000 melanoma cases are reported in US, 
among which approximately 7800 cases lead to death.  Its 
rate is increasing and may even get epidemic.10 It 
develops more in white race. According to conducted 
studies, such a growth may be attributed to the increase in 
daily activities outdoor or in places without sufficient 
protective cover, beach vacations, prolonged exposure to 
sun, and ozone depletion.11,12  
Skin cancer is a general health problem in Iran, which has 
always been the most prevalent cancer in our country. 
Excessive exposure to UV radiation of sun is the most 
important environmental factor in the incidence of these 
malignancies. Totally, in Iran the incidence rate of skin 
cancer is 10.1339 per 100000. The incidence rate of BCC 
is 7.53; of SCC is 1.79; and of malignant melanoma 
cancer is 0.39 per 100000.12 Although skin cancer is the 
most common type of cancer in Iran, its epidemiology 
and studies conducted in this regard are limited and 
scattered.13  
Melanoma and non-melanoma skin cancers are the most 
prevalent cancers in white-skinned people. Incidence rate 
of both pathologies of the tumor shows an increasing rate 
all over the world, but mortality rate due to cancer is 
either constant or decreasing. Increase in incidence rate of 
NMSC is probably because of a rise in individuals’ 
exposure to sun or UV radiation of light, an increase in 
outdoor activities, changes in clothing style, increased 
longevity, ozone depletion, genetics, and in some cases 
body immunosuppression.14  
Recently, skin cancer have increased to the extent that it 
has become the most common malignancy in the world 
resulting in severe inability and rather low mortality 
(except for melanoma which has higher mortality).15 Skin 
cancer is among the most common cancers all over the 
world,12 especially countries such as America, Europe, 
and Australia, where people have white and fair skin and 
blue and green eyes, are at peak incidence. In such 
countries one cause of mortality is malignant 
melanoma.16  
Skin cancer is among the most common malignancies in 
the world which leads to severe inability and low death 
rate. BCC is the most prevalent type of this cancer which 
is growing day by day.17 So far, no researches have been 
performed on patients visiting dermatology clinics in 
Ardabil city. The present study investigated the 
prevalence of melanoma and non-melanoma skin 
malignancies in patients visiting dermatology clinics, 
relative gender-based prevalence, and involved locus of 
body.  
METHODS 
This study is a retrospective descriptive one, and the 
research populations were 100000 medical records in 
dermatology clinics of Ardabil. The sample included 341 
medical cases which had undergone biopsy for suspicion 
Mohebbipour A et al. Int J Adv Med. 2015 Feb;2(1):38-43 
                                                           International Journal of Advances in Medicine | January-March 2015 | Vol 2 | Issue 1    Page 40 
of malignancy. Pathological responses were also attached 
to the records. Data related to each patient, including age, 
gender, pathological response of involved area/locus, 
duration of lesion, address, and job, were recorded, and, 
then, analyzed and interpreted through SPSS, version 19.   
RESULTS 
In this research there were 178 male (48%) and 193 
female (52%) participants. Most patients resided in 
Ardabil (50.9%). 32.9% of patients were housewives; 
26.2% were workers and self-employed; and 14.6% were 
employees. 90.2% had cigarette-smoking history. Among 
different types of skin cancers, BCC was the most 
prevalent one (72%) (Figure 1). The most commonly 
involved area (35.6%) was nose (Figure 2). 
 
Figure 1: Frequency kind of tumors confirmed by 
pathological results.  
 
Figure 2: Frequency of patients by lesion location.  
Most patients didn't have the conditions to be susceptible 
to any specific tumor (84.6%). After itching (48.0%), 
secretion (33.7%) and pain (22.9%) were most frequent 
signs of disease. 
Taking gender of patients into account it can be said that, 
BCC was more common in males (51.3%) than females 
(48.7%) (Figure 3). 
52.4% of those with BCC were from Ardabil, 47.6% 
were from other cities (Figure 4). According to this 
research, 49.8% of patients with BCC were from 50-70 
age groups (Figure 5). Most patients with BCC (107 
cases) and SCC (48 cases) stated that the duration of 
affliction was less than one year (Figure 6). Totally, the 
mean age of patients with malignant BCC and SCC was 
62.6 ± 14.7 and 64.6 ± 16.7 but difference was not 
statistically significant. The average duration of lesions in 
patients with BCC or SCC malignancies was 3.3 ± 0.26 
and 3.1 ± 0.8 but difference was not statistically 
significant between two groups.  
 
Figure 3: Frequency kind of tumors by sex.  
 
Figure 4: Frequency kind of tumors by patient’s 
residence place.  
 
Figure 5: Frequency kind of tumors by patient’s age.  
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Figure 6: Frequency kind of tumors by duration of 
the lesion.  
DISCUSSION 
In the present study Out of 100000 patients visiting 
dermatology clinics 371 patients have skin tumors and 
the prevalence of skin tumors was 0.37%. The most 
common type of tumor was pathological BCC (72%). A 
research conducted in skin unit of Sina hospital of 
Hamedan in1997-1999, showed that the most common 
pathological type was Noduler, and the most commonly 
involved area was nose.18 Another investigation carried 
out in Fatemi hospital of Ardabil in 2000-2001, revealed 
that among 35 hospitalized patients, BCC was the most 
frequent type (85.7%), and SCC, held the second position 
in terms of high frequency, and nose was the most 
common involved area.19 In another research performed 
in New Mexico in 2003, it was found that BCC 
prevalence had increased by 50% in males and 20% in 
females, and that SCC incidence rate had been doubled in 
both genders.20 A study in Essen university in Germany 
from 1995 to 1999, disclosed that SCC and BCC's 
incidence rate per 100000 was 11.2 cases in males, with 
the mean age of 43.7 and 4.4 cases in females with the 
mean age of 31.7.21 Also, another investigation in 
America in 2003 suggested that non-melanoma tumors 
had the highest incidence rate, and out of 1.3 million 
cases with skin malignancy 53,000 cases had melanoma 
which is a dangerous and malignant tumor. Findings of 
the present study conform to those of above study. 
Results of this study suggested that most of patients 
(52%) were females, which is in contrast with that of the 
research conducted in Mashhad which found that skin 
cancer was more common in males than females.22 
Likewise, in Sweden the BCC prevalence was higher in 
males compared to females.23 Therefore, it can be 
concluded that high incidence rate of the disease in males 
might be attributed to the large amount of their daily 
activities outdoors or in other sunny environments or to 
their high exposure to substances that cause cancer.24 In 
the study performed in Kerman on patients with SCC, the 
mean age was 60.25 Also in Collins et al.’s research26 in 
Holland, the mean age of patients is reported 64, which is 
almost in concordance with the results of the present 
study. In the current study, the mean age of incidence of 
three types of cancer showed significant differences. 
Regarding the distribution of place of residence, most 
patients (71%) of this study lived in urban areas which 
matches the findings of Yazdanian-far’s study in 
Hamedan province in which most patients, i.e. 70.8%, 
were from urban areas.11 
Similar to the findings of the study which showed that 
face is the most involved area, which can be ascribed to 
high exposure to sun, in an investigation performed in 
Kerman it was found that the involved areas in patients 
with SCC were head and neck in 77% of cases. However, 
in their studies Revenga Arranz et al. in Spain and 
Johnson et al. in England discovered that males are more 
prone to have melanoma in their upper body, while  
females are more likely to have it in their lower body. It 
is likely that these areas have more intense and frequent 
exposure to UV radiations and, thus, are more prone to 
sunburn and melanoma in turn.17  
Over the years under study, the incidence rate of skin 
cancer has been fluctuating in Ardabil province and is 
rather low compared to country's statistics. Therefore, it 
requires that environmental factors such as type of job, 
work hours outdoors, dryness and humidity of 
environment, cigarette-smoking and using other addictive 
materials and infectious factors to be investigated. Some 
limitations of this study are incomplete record of data in 
some cases and the possibility that patients had visited 
clinics out of province.  
This research showed that skin cancer is more common in 
females than males and often develops in old ages. 
Therefore, there should be screening programs for early 
prognosis of the disease in elderly males, especially those 
whose job requires to be excessively exposed to sun.  
Frequency of BCC, SCC, and malignant Melanoma was 
respectively 72%, 22.6%, and 5.4% in Ardabil, and there 
was a significant difference between frequency 
distribution of different types of skin cancers and 
individuals’ age (P = 0.013). The incidence rate of skin 
cancer was highest in the age range of 50-70 years 
(46.1%), and was the lowest in those below 30 years of 
age (2.9%). Over the years under study, i.e. 2002-2013, 
the highest incidence rate was concerned with the age 
range of 50-70 years and the lowest rate was related to 
the age range below 30; and Ardabil city with 50.9% had 
the highest incidence rate. In terms of the incidence rate 
of different types of skin cancer, our findings are 
compatible with those of previous studies.27-29 However, 
regarding the age group, in the study undertaken in Arak 
the highest incidence rate relates to individuals above 80. 
Additionally, gender pattern of this study is not in line 
with that of others27,28 since in this study SCC’s incidence 
was more common in females than males and BCC was 
more common in males. However, statistically speaking, 
the gender pattern did not show significant difference.   
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CONCLUSION 
Skin tumors are more prevalent in males than females 
which might be attributed to the fact than males are more 
exposed to sun than females. BCC was the most common 
non-melanoma tumor followed by SCC. Findings were in 
line with those of other studies. 
Suggestions  
Due to the effect of some risk factors such as age above 
40, maleness, massive exposure to sun, etc., in the 
incidence of such diseases , it is suggested that sunscreen 
and hat to be used and an attempt to be made  not to be 
excessively exposed to sun.  
Individuals who are treated with radiotherapy, 
irrespective of cause; patients undergoing grafts; and 
those with immunodeficiency or those who use 
immunosuppressive medicines should be occasionally (at 
least once in 6 months) examined by dermatologists.  
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